Price $110.80 |
Market Cap
2.78B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
28.1
|
P/B
6.92
|
P/S
2.56
|
Dividend %
-
|
|
P/CF
31.3
|
P/FCF
21.4
|
Op. Cash Flow
141.4K
|
FCF
5.3
|
|
Op. Margin
13.20%
|
Net Margin
6.50%
|
ROE
18.60%
|
ROI
24.90%
|
|
ROA
13.50%
|
EPS Growth
-29.50%
|
Current Ratio
2.4
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Digirad Corporation (DRAD) | $1.62 | - | 14.20% | 33.7M | Strong Buy |
| Neurometrix Inc (NURO) | $1.27 | - | - | 9.7M | Strong Buy |
| Aralez Pharmaceuticals Inc (ARLZ) | $0.31 | - | - | 24.7M | Strong Buy |
| NeoGenomics, Inc. (NEO) | $14.12 | - | - | 1.1B | Strong Buy |
| Nature's Sunshine Prod. (NATR) | $9.00 | - | 4.30% | 180.1M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
